| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.12.24 | Japan GDP Data Due On Monday | 473 | AFX News | BEIJING (dpa-AFX) - Japan will on Monday release Q3 figures for gross domestic product, highlighting a light day for Asia-Pacific economic activity. GDP is seen steady from the three months... ► Artikel lesen | |
| 08.12.24 | Sanofi-Aventis Announces Positive Results For Rilzabrutinib In Phase 3 ITP Study | 959 | AFX News | PARIS (dpa-AFX) - Sanofi-Aventis Groupe announced positive results from the pivotal LUNA 3 phase 3 study of rilzabrutinib in adults with persistent or chronic immune thrombocytopenia (ITP),... ► Artikel lesen | |
| 08.12.24 | Beam Therapeutics Announces Positive Data From Phase 1/2 Trial Of BEAM-101 In Sickle Cell Disease | 814 | AFX News | WASHINGTON (dpa-AFX) - Beam Therapeutics Inc. (BEAM) announced new safety and efficacy data from its BEACON Phase 1/2 clinical trial of BEAM-101 in patients with sickle cell disease (SCD) with... ► Artikel lesen | |
| 08.12.24 | Nektar's NKTR-255 After CD19 CAR-T Therapy Enhances Complete Response In R/R Large B-Cell Lymphoma | 1.051 | AFX News | WASHINGTON (dpa-AFX) - Nektar Therapeutics (NKTR) announced results of its Phase 2 proof-of-concept study, which evaluated NKTR-255 as an adjuvant treatment to enhance complete response rate... ► Artikel lesen | |
| 08.12.24 | AbbVie: Epcoritamab Combo Shows High Response Rates In R/R Follicular Lymphoma Trial | 796 | AFX News | WASHINGTON (dpa-AFX) - AbbVie (ABBV) announced updated results from the Phase 1b/2 EPCORE NHL-2 trial evaluating fixed-duration investigational epcoritamab, a CD3xCD20 bispecific T-cell-engaging... ► Artikel lesen | |
| 08.12.24 | REGN: Poze-Cemdi Combo In Phase 3 Result Shows Superior Hemolysis Control In PNH Vs. Ravulizumab | 839 | AFX News | WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals Inc. (REGN) announced positive updated Phase 3 data of an exploratory cohort from the ACCESS-1 trial investigating its first-in-class pozelimab... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 600 |
| EVOTEC | 334 |
| NOVO NORDISK | 323 |
| TESLA | 290 |
| RHEINMETALL | 246 |
| BYD | 233 |
| RENK GROUP | 169 |
| DEUTZ | 161 |
| TUI | 135 |
| APPLE | 132 |
| BASF | 132 |
| VOLKSWAGEN | 130 |
| NETFLIX | 127 |
| STEYR MOTORS | 127 |
| BAYER | 124 |
| PLUG POWER | 120 |
| AMAZON | 117 |
| ALMONTY | 113 |
| UNITEDHEALTH | 113 |
| XIAOMI | 108 |
| COMMERZBANK | 106 |
| E.ON | 105 |
| NEL | 105 |
| RWE | 105 |
| SIEMENS ENERGY | 100 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
